Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF for Thin Endometrium in Assisted Reproduction
NCT02996760Phase 3Terminated
- Sponsor
- International Vaccine Institute
- Start
- Mar 2018
- Primary completion
- Dec 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of PRGF-Endoret in thin endometrium, sponsored by International Vaccine Institute. Started Mar 2018; status: terminated.
02
Drugs
PRGF-Endoret
03
Conditions
thin endometrium
Beyond the preview
Go deeper on NCT02996760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02996760.